Industry › Clinical Trials
Press Releases
CanSinoBIO Launches Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health
CanSino Biologics Inc
Jun 20, 2025 18:06 HKT/SGT
NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment
NEC Corporation
Jun 18, 2025 12:40 HKT/SGT
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025
HighTide Therapeutics Inc.
Apr 24, 2025 18:43 HKT/SGT
Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA
HighTide Therapeutics Inc.
Apr 15, 2025 08:00 HKT/SGT
重磅發佈 - 君聖泰醫藥在JAMA Network Open發表熊去氧膽小檗鹼治療2型糖尿病的臨床2期研究數據 療效顯著 多重代謝獲益 市場前景廣闊
HighTide Therapeutics Inc.
Mar 04, 2025 16:48 HKT/SGT
重磅发布 - 君圣泰医药在JAMA Network Open发表熊去氧胆小檗碱治疗2型糖尿病的临床2期研究数据 疗效显著 多重代谢获益 市场前景广阔
HighTide Therapeutics Inc.
Mar 04, 2025 12:32 HKT/SGT
HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open
HighTide Therapeutics Inc.
Mar 04, 2025 12:26 HKT/SGT